New Biomarkers Strengthen McDonald Criteria for MS Diagnosis
Two promising biomarkers, the kappa free light chains (kFLC) index and central vein sign (CVS), have been incorporated into the revised 2024 McDonald criteria, offering improved diagnostic precision for multiple sclerosis (MS) and radiologically isolated syndrome (RIS).